Novavax | Zee News

Advertisement

Novavax News

08 Jun 2022

Novavax COVID-19 shots get FDA advisers' backing as 4th US option for adults

American adults who haven't yet gotten vaccinated against COVID-19 may soon get another choice Advisers to the Food and Drug Administration backed a more traditional type of shot The FDA must decide whether to authorise the protein vaccine made by Novavax as the nation's 4th coronavirus shot for adults

29 Dec 2021

Covovax authorisation is a vital step in India, says Novavax CEO

The Drugs Controller General of India (DCGI) has issued Emergency Use Authorization (EUA) for Covovax to prevent COVID-19 for adults 18 years old and above.

18 Dec 2021

Covovax gets emergency use approval

In view of the increasing threat of Omicron, WHO has approved the vaccine for children, Covovax

19 Nov 2021

India allows export of 20 million Novavax COVID vaccine doses to Indonesia

The government has also decided to allow the export of 10 million doses of a licensed version of the AstraZeneca shot made by SII, branded Covishield, to the global vaccine-sharing programme COVAX, two sources said.

Serum Institute India

17 Jun 2021

Serum Institute set for Novavax COVID vaccine trials on children from July

The Serum Institute of India hopes to start the clinical trials of Novavax's Covid-19 vaccine 'Covovax' on children in July. The manufacturers said they will be ready to launch it by September, pending approval from Centre.

16 Jun 2021

Covovax vaccine will be ready to launch in India by September: SII

SII has said that they will be ready to launch Covovax in India by September. Adar Poonawalla said that vaccine will be available by September if they get the nod.

15 Jun 2021

New COVID vaccine demonstrates 90 per cent overall efficacy: Novavax

As per reports, the Novavax vaccine can be stored in standard refrigerators, making it easier to distribute.

02 Jun 2021

Next-gen COVID shots: Cheaper, effective against more viruses

The pharma companies aim to develop shots that will be more effective against certain variants of the SARS-CoV-2 virus, that causes COVID-19 Most companies investing in COVID-19 vaccines are banking on the idea that regular boosters will be necessary

23 May 2021

UK launches 3rd booster dose trial of 7 COVID vax

The trial will assess COVID-19 vaccines of Oxford-AstraZeneca, Pfizer-BioNTech, Moderna, Novavax, Valneva, Janssen and Curevac Cov-Boost, aims to begin in June and recruit 3,000 people of all ages who had their first dose in December or January

COVID-19 vaccine

30 Nov 2020

US COVID-19 vaccine trial in coming weeks after second delay: Novavax

Novavax has been working closely with the US Food and Drug Administration to greenlight the use of the vaccine The company also said it has completed enrollment for its 15,000 participant UK trial More than 25% of enrollees in the UK trial are over the age of 65

Loading...

NEWS ON ONE CLICK